Daiichi Sankyo
Edge Colecchia is an accomplished professional in the life sciences and digital transformation sectors, currently serving as the Digital Transformation Lead and Director of Informatics at Daiichi Sankyo US since November 2024. Previously, Edge held the role of Digital Health Implementation Lead at Evinova, focusing on enhancing clinical trials through digital platforms. Edge's experience at Bristol Myers Squibb as Associate Director of EDC Management involved overseeing EDC system management and resource management. At Labcorp Drug Development, Edge progressed from Associate Director to Director of eClinical Solutions, managing eClinical programming resources and providing strategic recommendations. Edge holds two Master of Science degrees, one in Neurobiology from Northwestern University and another in Computer Science from the University of Chicago.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.